Sony Tuteja, Pharm.D., MS, BCPS, FAHA
Research Assistant Professor of Medicine (Translational Medicine and Human Genetics)
Affiliate Member, Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania
Member, Institute for Translational Medicine and Therapeutics, University of Pennsylvania
Member, Cardiovascular Institute
Heath Science Specialist, Corporal Michael J. Crescencz VA Medical Center, Philadelphia, PA
Assistant Director, Pharmacogenomics, Penn Center for Precision Medicine, University of Pennsylvania
Department: Medicine
Contact information
Hospital of the University of Pennsylvania
Maloney Building 9013
Philadelphia, PA 19104
Philadelphia, PA 19104-5158
Maloney Building 9013
Philadelphia, PA 19104
Philadelphia, PA 19104-5158
Office: 215-615-8785
Fax: 215-573-7272
Fax: 215-573-7272
Email:
sonyt@pennmedicine.upenn.edu
sonyt@pennmedicine.upenn.edu
Publications
Education:
Pharm.D.
University of Michigan, 1997.
MS
University of Iowa (Translational Biomedical Research), 2010.
Permanent linkPharm.D.
University of Michigan, 1997.
MS
University of Iowa (Translational Biomedical Research), 2010.
Description of Clinical Expertise
Clinical Implementation, PharmacogeneticsDescription of Research Expertise
Pharmacogenomics, Precision Medicine, Metabolomics, PharmacologySelected Publications
Tuteja Sony, Wang Lu, Dunbar Richard L, Chen Jinbo, DerOhannessian Stephanie, Marcovina Santica M, Elam Marshall, Lader Ellis, Rader Daniel J: Genetic coding variants in the niacin receptor, hydroxyl-carboxylic acid receptor 2, and response to niacin therapy. Pharmacogenetics and genomics 27(8): 285-293, Aug 2017.Empey Philip E, Stevenson James M, Tuteja Sony, Weitzel Kristin W, Angiolillo Dominick J, Beitelshees Amber L, Coons James C, Duarte Julio D, Franchi Francesco, Jeng Linda J B, Johnson Julie A, Kreutz Rolf P, Limdi Nita A, Maloney Kristin A, Owusu Obeng Aniwaa, Peterson Josh F, Petry Natasha, Pratt Victoria M, Rollini Fabiana, Scott Stuart A, Skaar Todd C, Vesely Mark R, Stouffer George A, Wilke Russell A, Cavallari Larisa H, Lee Craig R: Multi-site investigation of strategies for the implementation of CYP2C19 genotype-guided antiplatelet therapy. Clinical pharmacology and therapeutics 104(4): 664-674, Oct 2018.
Cavallari LH, Beitelshees AL, Blake KV, Dressler LG, Duarte JD, Elsey A, Eichmeyer JN, Empey PE, Franciosi JP, Hicks JK, Holmes AM, Jeng L, Lee CR, Lima JJ, Limdi NA, Modlin J, Obeng AO, Petry N, Pratt VM, Skaar TC, Tuteja S, Voora D, Wagner M, Weitzel KW, Wilke RA, Peterson JF, Johnson JA: The implementing genomics in practice (IGNITE) pharmacogenetics interest group: An opportunity for building evidence with pharmacogenetics implementation. Clinical and Translational Science 10(3): 143-143, May 2017.
Dunbar RL, Goel H, Tuteja S, Brent C, Babbar Z, Lalic D, Gelfand JM, Rader DJ, Grove GL: Measuring physical properties of erythema by laser Doppler flowmetry, white-light spectroscopy, colorimetry, thermometry, and eicosanoid Biomarkers. Journal of Lipid Research 58(4): 783-797, April 2017.
Quatromoni N, Tuteja S, Kolansky DM, Matthai WH and Giri J: Novel anti-platelet agents in acute coronary syndrome: mechanisms of action and opportunities to tailor therapy. Curr Atheroscler Rep 7(5): 501, May 2015.
Tuteja S, Rader DJ: High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigm. Clinical Pharmacology and Therapeutics 96(1): 48-56, Jul 2014.
Tuteja S and Rader DJ: Dyslipidaemia: cardiovascular prevention—end of the road for niacin? Nature Reviews Endocrinology 10(11): 646-647, Nov 2014.
Tuteja S, Duffy D, Dunbar RL, Movva R, Gadi R, Bloedon LT, Cuchel M: Pharmacokinetic interactions of the microsomal triglyceride transfer protein inhibitor, lomitapide, with drugs commonly used in the management of hypercholesterolemia. Pharmacotherapy 34(3): 227-239, Mar 2014.
Tuteja S, Haynes K, Zayac C, Sprague JE, Bernhardt B, Pyeritz R: Community pharmacists' attitudes towards pharmacogenetic testing. Personalized Medicine 10(8): 793-800, Nov 2013.